Diet and drug therapy: a dynamic duo for reducing coronary heart disease risk
| Autor: | Kirsten F. Clemmer, Amy E. Binkoski, Penny M. Kris-Etherton, Stacie M. Coval, Guixiang Zhao |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
medicine.medical_specialty
Population Psychological intervention Coronary Disease chemistry.chemical_compound Pharmacotherapy Risk Factors Internal medicine medicine Humans education National Cholesterol Education Program Angiology education.field_of_study Cholesterol business.industry Anticholesteremic Agents Cholesterol LDL Feeding Behavior Combined Modality Therapy Coronary heart disease Endocrinology Treatment Outcome chemistry Practice Guidelines as Topic lipids (amino acids peptides and proteins) Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Lipoprotein |
| Zdroj: | Current atherosclerosis reports. 3(6) |
| ISSN: | 1523-3804 |
| Popis: | A large proportion of the United States population requires aggressive low-density lipoprotein (LDL) cholesterol- lowering therapy to meet the new treatment guidelines established by the National Cholesterol Education Program Adult Treatment Panel III. This has further widened the gap between the number of people being treated compared with those who should be treated. Moreover, many people being treated do not meet their LDL cholesterol goal. Diet and healthy lifestyle practices remain the cornerstone of treatment to lower LDL cholesterol. Pharmacologic therapy has assumed an increasingly important role in reaching LDL cholesterol goals. Diet and healthy-lifestyle interventions have been shown to augment the benefits of cholesterol-lowering drugs. Together, this dynamic duo provides the most effective clinical means identified to date for maximally lowering LDL cholesterol levels. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink